Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Randomized Evaluation of Vinorelbine Versus Gemcitabine Chemotherapy Mobilization of Stem Cells in Myeloma Patients

Barbara Jeker, Sarah Farag, Urban Novak, Ulrike Bacher, Behrouz Mansouri Taleghani, Qiyu Li, Thomas Pabst, MD

Blood (2019) 134 (Supplement_1): 1963.

https://doi.org/10.1182/blood-2019-127848

Published: 2019

Journal Articles

Acquired Hemophilia and Plasma Cell Neoplasms, a Rare Association

Katarzyna Aleksandra Jalowiec, Martin Andres, Behrouz Mansouri Taleghani, Anne Angelillo-Scherrer, MD PhD, Alicia Rovo, Johanna A. Kremer Hovinga, MD Prof

Blood (2019) 134 (Supplement_1): 4930.

https://doi.org/10.1182/blood-2019-128048

Published: 2019

Journal Articles

Autologous Stem Cell Transfusions on Multiple Days in Patients with Multiple Myeloma - Does It Matter?

Thomas Pabst, MD, Sebastian Moser, Ulrike Bacher, Barbara Jeker, Behrouz Mansouri Taleghani, Prof., Urban Novak

Blood (2019) 134 (Supplement_1): 3252.

https://doi.org/10.1182/blood-2019-127940

Published: 2019

Journal Articles

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Beatrice U. Mueller, MD, Sandra Keller, MD, Katja Seipel, PhD, Behrouz Mansouri Taleghani, MD, Thomas Pabst, MD

Blood (2015) 126 (23): 5436.

https://doi.org/10.1182/blood.V126.23.5436.5436

Published: 2015

Journal Articles

Transfusion Efficacy of Apheresis Platelet Concentrates (APCs) Irradiated in Advance Is Significantly Lower Compared to Products Irradiated within 24 hours Before Transfusion.

Friedgard Julmy, MT, Roland A Ammann, MD, Behrouz Mansouri Taleghani, MD, Stefano Fontana, MD, Andreas Hirt, MD, Kurt Leibundgut, MD

Blood (2009) 114 (22): 3139.

https://doi.org/10.1182/blood.V114.22.3139.3139

Published: 2009

Journal Articles

Apart from Blood Group A2, ABO Antigen Incompatible Platelet Transfusions Result in Significantly Lower Corrected Count Increments (CCI) in Children.

Friedgard Julmy, MT, Behrouz Mansouri Taleghani, MD, Roland A. Ammann, MD, Stefano Fontana, MD, Kurt Leibundgut, MD

Blood (2006) 108 (11): 579.

https://doi.org/10.1182/blood.V108.11.579.579

Published: 2006

Journal Articles

Transfusion Effectiveness of Single-Donor Apheresis Platelets Depends on Apheresis Device and Platelet Yield: Results of a Prospective Study in Children.

Friedgard Julmy, MT, Roland A. Ammann, MD, Stefano Fontana, MD, Behrouz Mansouri Taleghani, MD, Kurt E. Leibundgut, MD

Blood (2005) 106 (11): 951.

https://doi.org/10.1182/blood.V106.11.951.951

Published: 2005

NARROW

A Randomized Evaluation of Vinorelbine Versus Gemcitabine Chemotherapy Mobilization of Stem Cells in Myeloma Patients

Acquired Hemophilia and Plasma Cell Neoplasms, a Rare Association

Autologous Stem Cell Transfusions on Multiple Days in Patients with Multiple Myeloma - Does It Matter?

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Transfusion Efficacy of Apheresis Platelet Concentrates (APCs) Irradiated in Advance Is Significantly Lower Compared to Products Irradiated within 24 hours Before Transfusion.

Apart from Blood Group A2, ABO Antigen Incompatible Platelet Transfusions Result in Significantly Lower Corrected Count Increments (CCI) in Children.

Transfusion Effectiveness of Single-Donor Apheresis Platelets Depends on Apheresis Device and Platelet Yield: Results of a Prospective Study in Children.

Email alerts

ASH Publications

American Society of Hematology

A Randomized Evaluation of Vinorelbine Versus Gemcitabine Chemotherapy Mobilization of Stem Cells in Myeloma Patients

Acquired Hemophilia and Plasma Cell Neoplasms, a Rare Association

Autologous Stem Cell Transfusions on Multiple Days in Patients with Multiple Myeloma - Does It Matter?

Stem Cell Mobilization Chemotherapy with Gemcitabine Is Effective and Safe in Myeloma Patients with Bortezomib Induced Neurotoxicity

Transfusion Efficacy of Apheresis Platelet Concentrates (APCs) Irradiated in Advance Is Significantly Lower Compared to Products Irradiated within 24 hours Before Transfusion.

Apart from Blood Group A2, ABO Antigen Incompatible Platelet Transfusions Result in Significantly Lower Corrected Count Increments (CCI) in Children.

Transfusion Effectiveness of Single-Donor Apheresis Platelets Depends on Apheresis Device and Platelet Yield: Results of a Prospective Study in Children.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only